No Data
No Data
Express News | Hologic Shares Trims Gain, Last up 0.6%; FDA Says Hologic, Inc. Recalls Biozorb Marker Due to Complications With Implanted Devices
Express News | FDA: FDA Identified Hologic's Recall of Biozorb Marker as a Class I Recall
Express News | Hologic Recalls BioZorb Marker Due To Complications With Implanted Devices
Express News | Hologic, Inc. Recalls Biozorb Marker Due To Reported Complications And Adverse Events With Implanted Devices - FDA
Hologic to Webcast Presentations at Upcoming Investor Conferences
MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #holx--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences: 2024 Leerink Partners Healt
Meditrina Welcomes Senior Vice President of Global Sales to Lead Expansion Efforts and Manage Rapid Growth
No Data